Growth is apparent, ability to measure impact is not

‍

In this JMIR article, you'll learn about:

‍

• We sought to comprehensively examine the topic of clinical robustness in digital health companies by using a more comprehensive definition of clinical rigor and examining companies' public claims across the most in-depth database of US-based digital health companies.

‍

• Digital health companies are defined as those that build and sell digital technologies in health care, and data was collected through August 3, 2021.

‍

• Claim types include clinical, economic, and engagement. Data collection was completed by at least 3 authors, with blinded cross-review, and a "clinical robustness" score was calculated for 224 companies. Average company funding was similar across phases of care.

‍